Skip to main content
. 2016 Feb 3;7(9):9925–9938. doi: 10.18632/oncotarget.7155

Table 1. Clinical characteristics of the patients with breast cancer.

Samples HER2 positive
(IHC + + + and + + with
gene amplification by
FISH)
HER2 negative
(IHC−, +, and
++ without gene
amplification by FISH)
Normal control p
Sample No. 36 60 79
Age(year) 52.3(31~82) 53.1(31~78) 46.4(24~86) >0.05
ER positive n=11 (5 for test set) as Luminal B subtype n=42 (22 for test set) as Luminal A subtype \
ER negative n=25 (10 for test set) as HER2-enriched subtype n=18 (8 for test set) as Basal-like subtype \
TNM classification stage I 6 25 \
IIA 19 20 \
IIIA 1 1 \
IIIB 10 14 \

HER2, human epidermal growth factor receptor 2;

ER, estrogen receptor;

IHC, immunohistochemistry;

FISH, fluorescence in situ hybridization.